Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
PARP means poly (adenosine diphosphate [ADP] -ribose) polymerase. It is a family of 17 enzymes that combine several (poly) units of ADP-ribose in a chain (the PAR chain) and transfers them to the target proteins. This helps to restore DNA when it is damaged. DNA can be damaged by many factors, including exposure to UV rays, radiation, some anti-cancer drugs or other substances in the environment. PARP inhibitors block an enzyme critical to the repair of single stranded breaks in DNA. Inhibition of this DNA repair enzyme can lead to cell death, particularly in cancer cells that carry deficiency in other DNA repair pathways.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA PARP (Poly ADP-Ribose Polymerase) Inhibitor market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA PARP (Poly ADP-Ribose Polymerase) Inhibitor market. Detailed analysis of key players, along with key growth strategies adopted by PARP (Poly ADP-Ribose Polymerase) Inhibitor industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Clovis Oncology
AstraZeneca
Tesaro
Abbvie
By Type:
Lynparza
Diraparib
Rucaparib
Talazoparib
Others
By End-User:
Hospitals
Pharmacial
Retail
Online
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of PARP (Poly ADP-Ribose Polymerase) Inhibitor Market
-
1.3 Market Segment by Type
-
1.3.1 USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and Growth Rate of Lynparza from 2016 to 2027
-
1.3.2 USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and Growth Rate of Diraparib from 2016 to 2027
-
1.3.3 USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and Growth Rate of Rucaparib from 2016 to 2027
-
1.3.4 USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and Growth Rate of Talazoparib from 2016 to 2027
-
1.3.5 USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and Growth Rate of Pharmacial from 2016 to 2027
-
1.4.3 USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and Growth Rate of Retail from 2016 to 2027
-
1.4.4 USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and Growth Rate of Online from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of PARP (Poly ADP-Ribose Polymerase) Inhibitor Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of PARP (Poly ADP-Ribose Polymerase) Inhibitor by Major Types
-
3.4.1 Market Size and Growth Rate of Lynparza
-
3.4.2 Market Size and Growth Rate of Diraparib
-
3.4.3 Market Size and Growth Rate of Rucaparib
-
3.4.4 Market Size and Growth Rate of Talazoparib
-
3.4.5 Market Size and Growth Rate of Others
4 Segmentation of PARP (Poly ADP-Ribose Polymerase) Inhibitor Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of PARP (Poly ADP-Ribose Polymerase) Inhibitor by Major End-Users
-
4.4.1 Market Size and Growth Rate of PARP (Poly ADP-Ribose Polymerase) Inhibitor in Hospitals
-
4.4.2 Market Size and Growth Rate of PARP (Poly ADP-Ribose Polymerase) Inhibitor in Pharmacial
-
4.4.3 Market Size and Growth Rate of PARP (Poly ADP-Ribose Polymerase) Inhibitor in Retail
-
4.4.4 Market Size and Growth Rate of PARP (Poly ADP-Ribose Polymerase) Inhibitor in Online
5 Market Analysis by Regions
-
5.1 USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Analysis by Regions
-
5.2 USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Landscape Analysis
-
6.1 West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Landscape Analysis by Major Types
-
6.2 West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Landscape Analysis by Major End-Users
7 South USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Landscape Analysis
-
7.1 South USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Landscape Analysis by Major Types
-
7.2 South USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Landscape Analysis by Major End-Users
8 Middle West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Landscape Analysis
-
8.1 Middle West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Landscape Analysis by Major Types
-
8.2 Middle West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Landscape Analysis by Major End-Users
9 Northeast USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Landscape Analysis
-
9.1 Northeast USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Landscape Analysis by Major Types
-
9.2 Northeast USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Clovis Oncology
-
10.1.1 Clovis Oncology Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 AstraZeneca
-
10.2.1 AstraZeneca Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Tesaro
-
10.3.1 Tesaro Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Abbvie
-
10.4.1 Abbvie Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and Growth Rate of Lynparza from 2016 to 2027
-
Figure USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and Growth Rate of Diraparib from 2016 to 2027
-
Figure USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and Growth Rate of Rucaparib from 2016 to 2027
-
Figure USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and Growth Rate of Talazoparib from 2016 to 2027
-
Figure USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and Growth Rate of Pharmacial from 2016 to 2027
-
Figure USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and Growth Rate of Retail from 2016 to 2027
-
Figure USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and Growth Rate of Online from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of PARP (Poly ADP-Ribose Polymerase) Inhibitor Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of PARP (Poly ADP-Ribose Polymerase) Inhibitor
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of PARP (Poly ADP-Ribose Polymerase) Inhibitor by Different Types from 2016 to 2027
-
Table Consumption Share of PARP (Poly ADP-Ribose Polymerase) Inhibitor by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Lynparza
-
Figure Market Size and Growth Rate of Diraparib
-
Figure Market Size and Growth Rate of Rucaparib
-
Figure Market Size and Growth Rate of Talazoparib
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of PARP (Poly ADP-Ribose Polymerase) Inhibitor by Different End-Users from 2016 to 2027
-
Table Consumption Share of PARP (Poly ADP-Ribose Polymerase) Inhibitor by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Pharmacial
-
Figure Market Size and Growth Rate of Retail
-
Figure Market Size and Growth Rate of Online
-
Table USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Production by Regions
-
Table USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Share by Regions
-
Figure USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Share by Regions in 2016
-
Figure USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Share by Regions in 2021
-
Figure USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Share by Regions in 2027
-
Table USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption by Regions
-
Table USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by Regions
-
Figure USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by Regions in 2016
-
Figure USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by Regions in 2021
-
Figure USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by Regions in 2027
-
Table West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption by Types from 2016 to 2027
-
Table West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by Types from 2016 to 2027
-
Figure West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by Types in 2016
-
Figure West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by Types in 2021
-
Figure West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by Types in 2027
-
Table West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption by End-Users from 2016 to 2027
-
Table West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by End-Users from 2016 to 2027
-
Figure West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by End-Users in 2016
-
Figure West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by End-Users in 2021
-
Figure West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by End-Users in 2027
-
Table South USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption by Types from 2016 to 2027
-
Table South USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by Types from 2016 to 2027
-
Figure South USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by Types in 2016
-
Figure South USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by Types in 2021
-
Figure South USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by Types in 2027
-
Table South USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption by End-Users from 2016 to 2027
-
Table South USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by End-Users from 2016 to 2027
-
Figure South USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by End-Users in 2016
-
Figure South USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by End-Users in 2021
-
Figure South USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by End-Users in 2027
-
Table Middle West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption by Types from 2016 to 2027
-
Table Middle West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by Types in 2016
-
Figure Middle West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by Types in 2021
-
Figure Middle West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by Types in 2027
-
Table Middle West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption by End-Users from 2016 to 2027
-
Table Middle West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by End-Users in 2016
-
Figure Middle West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by End-Users in 2021
-
Figure Middle West USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by End-Users in 2027
-
Table Northeast USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption by Types from 2016 to 2027
-
Table Northeast USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by Types in 2016
-
Figure Northeast USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by Types in 2021
-
Figure Northeast USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by Types in 2027
-
Table Northeast USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption by End-Users from 2016 to 2027
-
Table Northeast USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by End-Users in 2016
-
Figure Northeast USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by End-Users in 2021
-
Figure Northeast USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Clovis Oncology
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Clovis Oncology
-
Figure Sales and Growth Rate Analysis of Clovis Oncology
-
Figure Revenue and Market Share Analysis of Clovis Oncology
-
Table Product and Service Introduction of Clovis Oncology
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Tesaro
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tesaro
-
Figure Sales and Growth Rate Analysis of Tesaro
-
Figure Revenue and Market Share Analysis of Tesaro
-
Table Product and Service Introduction of Tesaro
-
Table Company Profile and Development Status of Abbvie
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbvie
-
Figure Sales and Growth Rate Analysis of Abbvie
-
Figure Revenue and Market Share Analysis of Abbvie
-
Table Product and Service Introduction of Abbvie
-
